New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Equillium, Inc.
EQ
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

42M

Biotechnology

Next Earning date - 13 Nov 2024

42M

Biotechnology

Next Earning date - 13 Nov 2024

1.18USD
Shape-0.04 ( -2.88%)
favorite-chart

Relative Strenght

96
favorite-chart

Volume Buzz

22%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

64%

Quote Panel

Shape
Updated October 26, 2024
1W 5.36 % 1M 41.79 % 3M 49.69 % 1Y 122.64 %

Key Metrics

Shape
  • Market Cap

    41.80M


  • Shares Outstanding

    35.42M


  • Share in Float

    17.41M


  • Dividende

    0


  • Earning Date

    13 Nov 2024


  • Price Target

    1.18


  • Average Volume

    139175


  • Beta

    1.826


  • Range

    0.45-3.25


  • Industry

    Biotechnology


  • Website

    https://equilliumbio.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.98x

P/S Ratio

1.86x

P/B Ratio

0.0

Debt/Equity

-19.5%

Net Margin

$-0.2

EPS

How EQ compares to sector?

P/E Ratio

Relative Strength

Shape

EQ

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$26M

Shape86%

2025-Revenue

$0.78

Shape-5965%

2025-EPS

$8M

Shape12785%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.40
vs -0.35

Q4.22

arrow
arrow

+122%

0.08
vs -0.36

Q1.23

arrow
arrow

N/A

-0.11
vs -0.45

Q2.23

arrow
arrow

N/A

-0.10
vs -0.41

Q3.23

arrow
arrow

N/A

-0.11
vs -0.40

Q4.23

arrow
arrow

N/A

-0.07
vs 0.08

Q1.24

arrow
arrow

N/A

-0.08
vs -0.11

Q2.24

arrow
arrow

+110%

0.01
vs -0.10

Q3.24

arrow
arrow

+361%

0.29
vs -0.11

Q4.24

arrow
arrow

N/A

-0.29
vs -0.07

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

15.8M  vs NA

Q1.23

arrow
arrow

NA

8.9M  vs NA

Q2.23

arrow
arrow

NA

9.1M  vs NA

Q3.23

arrow
arrow

NA

8.9M  vs NA

Q4.23

arrow
arrow

-42%

9.2M  vs 15.8M

Q1.24

arrow
arrow

+20%

10.7M  vs 8.9M

Q2.24

arrow
arrow

+52%

13.9M  vs 9.1M

Q3.24

arrow
arrow

+141%

21.4M  vs 8.9M

Q4.24

arrow
arrow

-94%

550K  vs 9.2M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-48%

-0.48
vs -0.37

Q4.22

arrow
arrow

+12%

0.12
vs -0.48

Q1.23

arrow
arrow

-13%

-0.13
vs 0.12

Q2.23

arrow
arrow

-12%

-0.12
vs -0.13

Q3.23

arrow
arrow

-15%

-0.15
vs -0.12

Q4.23

arrow
arrow

-10%

-0.10
vs -0.15

Q1.24

arrow
arrow

-13%

-0.13
vs -0.10

Q2.24

arrow
arrow

+2%

0.02
vs -0.13

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

32

32
vs 25

28%

Q4.22

arrow
arrow

34

34
vs 32

6%

Q1.23

arrow
arrow

29

29
vs 34

-15%

Q2.23

arrow
arrow

28

28
vs 29

-3%

Q3.23

arrow
arrow

27

27
vs 28

-4%

Q4.23

arrow
arrow

24

24
vs 27

-11%

Q1.24

arrow
arrow

30

30
vs 24

25%

Q2.24

arrow
arrow

25

25
vs 30

-17%

Earnings Growth

Latest News